ArticleGynecologic oncology reports2025

Maintenance bevacizumab following chemotherapy is associated with improved survival in patients with advanced and recurrent cervical cancer in a single-institution retrospective study.

Johanna Kelley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.